Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -137,018 | -368,198 | -308,510 | -249,461 | -90,393 |
| Depreciation Amortization | 75,674 | 13,030 | 9,476 | 7,871 | 5,006 |
| Income taxes - deferred | -1,812 | 2,708 | 0 | 0 | 0 |
| Accounts receivable | 2,986 | 16,511 | 10,960 | 12,486 | -7,728 |
| Accounts payable and accrued liabilities | -8,920 | 3,103 | -4,184 | 2,833 | 2,998 |
| Other Working Capital | -2,474 | 492 | 8,560 | 36,332 | 14,510 |
| Other Operating Activity | 19,649 | 28,347 | 37,394 | 26,522 | -12,817 |
| Operating Cash Flow | $-51,915 | $-304,007 | $-246,304 | $-163,417 | $-88,424 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -433 | 7,520 | -5,164 | -4,983 | -4,203 |
| Purchase Of Investment | -107,012 | -467,914 | -295,439 | -247,014 | -93,493 |
| Sale Of Investment | 148,043 | 826,229 | 626,424 | 466,423 | 227,974 |
| Investing Cash Flow | $40,598 | $365,835 | $325,821 | $214,426 | $130,278 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 758 | 655 | 655 | 188 |
| Other Financing Activity | 0 | 750 | 750 | 750 | 750 |
| Financing Cash Flow | $N/A | $1,508 | $1,405 | $1,405 | $938 |
| Exchange Rate Effect | 45 | -327 | -382 | -87 | -17 |
| Beginning Cash Position | 88,227 | 25,218 | 25,218 | 25,218 | 25,218 |
| End Cash Position | 76,955 | 88,227 | 105,758 | 77,545 | 67,993 |
| Net Cash Flow | $-11,272 | $63,009 | $80,540 | $52,327 | $42,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,915 | -304,007 | -246,304 | -163,417 | -88,424 |
| Capital Expenditure | -433 | -5,676 | -5,164 | -4,983 | -4,203 |
| Free Cash Flow | -52,348 | -309,683 | -251,468 | -168,400 | -92,627 |